A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand

Zaheer Ud Din Babar, Piyush Grover, Rachael Butler, Lynne Bye, Janie Sheridan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: The objective of this study was to evaluate general practitioners' (GPs) perceptions regarding access to medicines in New Zealand. Design: Qualitative. Setting: Primary care. Participants: GPs. Main outcome measures: GPs' views and perceptions. Results: GPs were of the view that the current range of medicines available in New Zealand was reasonable; however, it was acknowledged that there were some drugs that patients were missing out on. When considering the range of subsidised medicines available in New Zealand, some GPs felt that there had been an improvement over recent years. It was highlighted that unexpected funding changes could create financial barriers for some patients and that administrative procedures and other complexities created barriers in receiving a subsidy for restricted medicines. GPs also reported problems with the availability and sole supply of certain medicines and claimed that switching from a branded medicine to its generic counterpart could be disruptive for patients. Conclusions: The research concluded that although there were some issues with the availability of certain drugs, most GPs were satisfied with the broader access to medicines situation in New Zealand. This view is to contrary to the situation presented by the pharmaceutical industry. The issues around sole supply, the use of generic medicines and the administrative barriers regarding funding of medicines could be improved with better systems. The current work provides a solid account of what GPs see as the advantages and disadvantages of the current system and how they balance these demands in practice.

Original languageEnglish
Article numberA30
JournalBMJ Open
Volume2
Issue number2
Early online date28 Mar 2012
DOIs
Publication statusPublished - 27 Apr 2012
Externally publishedYes

Fingerprint

New Zealand
General Practitioners
Drug Industry
Pharmaceutical Preparations
Primary Health Care
Medicine
Outcome Assessment (Health Care)
Research

Cite this

Babar, Zaheer Ud Din ; Grover, Piyush ; Butler, Rachael ; Bye, Lynne ; Sheridan, Janie. / A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand. In: BMJ Open. 2012 ; Vol. 2, No. 2.
@article{80668f77df9a41018b52ef7418c0382f,
title = "A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand",
abstract = "Objective: The objective of this study was to evaluate general practitioners' (GPs) perceptions regarding access to medicines in New Zealand. Design: Qualitative. Setting: Primary care. Participants: GPs. Main outcome measures: GPs' views and perceptions. Results: GPs were of the view that the current range of medicines available in New Zealand was reasonable; however, it was acknowledged that there were some drugs that patients were missing out on. When considering the range of subsidised medicines available in New Zealand, some GPs felt that there had been an improvement over recent years. It was highlighted that unexpected funding changes could create financial barriers for some patients and that administrative procedures and other complexities created barriers in receiving a subsidy for restricted medicines. GPs also reported problems with the availability and sole supply of certain medicines and claimed that switching from a branded medicine to its generic counterpart could be disruptive for patients. Conclusions: The research concluded that although there were some issues with the availability of certain drugs, most GPs were satisfied with the broader access to medicines situation in New Zealand. This view is to contrary to the situation presented by the pharmaceutical industry. The issues around sole supply, the use of generic medicines and the administrative barriers regarding funding of medicines could be improved with better systems. The current work provides a solid account of what GPs see as the advantages and disadvantages of the current system and how they balance these demands in practice.",
author = "Babar, {Zaheer Ud Din} and Piyush Grover and Rachael Butler and Lynne Bye and Janie Sheridan",
year = "2012",
month = "4",
day = "27",
doi = "10.1136/bmjopen-2011-000518",
language = "English",
volume = "2",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "British Medical Journal Publishing Group",
number = "2",

}

A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand. / Babar, Zaheer Ud Din; Grover, Piyush; Butler, Rachael; Bye, Lynne; Sheridan, Janie.

In: BMJ Open, Vol. 2, No. 2, A30, 27.04.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A qualitative evaluation of general practitioners' perceptions regarding access to medicines in New Zealand

AU - Babar, Zaheer Ud Din

AU - Grover, Piyush

AU - Butler, Rachael

AU - Bye, Lynne

AU - Sheridan, Janie

PY - 2012/4/27

Y1 - 2012/4/27

N2 - Objective: The objective of this study was to evaluate general practitioners' (GPs) perceptions regarding access to medicines in New Zealand. Design: Qualitative. Setting: Primary care. Participants: GPs. Main outcome measures: GPs' views and perceptions. Results: GPs were of the view that the current range of medicines available in New Zealand was reasonable; however, it was acknowledged that there were some drugs that patients were missing out on. When considering the range of subsidised medicines available in New Zealand, some GPs felt that there had been an improvement over recent years. It was highlighted that unexpected funding changes could create financial barriers for some patients and that administrative procedures and other complexities created barriers in receiving a subsidy for restricted medicines. GPs also reported problems with the availability and sole supply of certain medicines and claimed that switching from a branded medicine to its generic counterpart could be disruptive for patients. Conclusions: The research concluded that although there were some issues with the availability of certain drugs, most GPs were satisfied with the broader access to medicines situation in New Zealand. This view is to contrary to the situation presented by the pharmaceutical industry. The issues around sole supply, the use of generic medicines and the administrative barriers regarding funding of medicines could be improved with better systems. The current work provides a solid account of what GPs see as the advantages and disadvantages of the current system and how they balance these demands in practice.

AB - Objective: The objective of this study was to evaluate general practitioners' (GPs) perceptions regarding access to medicines in New Zealand. Design: Qualitative. Setting: Primary care. Participants: GPs. Main outcome measures: GPs' views and perceptions. Results: GPs were of the view that the current range of medicines available in New Zealand was reasonable; however, it was acknowledged that there were some drugs that patients were missing out on. When considering the range of subsidised medicines available in New Zealand, some GPs felt that there had been an improvement over recent years. It was highlighted that unexpected funding changes could create financial barriers for some patients and that administrative procedures and other complexities created barriers in receiving a subsidy for restricted medicines. GPs also reported problems with the availability and sole supply of certain medicines and claimed that switching from a branded medicine to its generic counterpart could be disruptive for patients. Conclusions: The research concluded that although there were some issues with the availability of certain drugs, most GPs were satisfied with the broader access to medicines situation in New Zealand. This view is to contrary to the situation presented by the pharmaceutical industry. The issues around sole supply, the use of generic medicines and the administrative barriers regarding funding of medicines could be improved with better systems. The current work provides a solid account of what GPs see as the advantages and disadvantages of the current system and how they balance these demands in practice.

UR - http://www.scopus.com/inward/record.url?scp=84860153622&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2011-000518

DO - 10.1136/bmjopen-2011-000518

M3 - Article

VL - 2

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 2

M1 - A30

ER -